FI119414B - Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17beta-estradioliprekursoreiden antamiseksi - Google Patents

Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17beta-estradioliprekursoreiden antamiseksi Download PDF

Info

Publication number
FI119414B
FI119414B FI972579A FI972579A FI119414B FI 119414 B FI119414 B FI 119414B FI 972579 A FI972579 A FI 972579A FI 972579 A FI972579 A FI 972579A FI 119414 B FI119414 B FI 119414B
Authority
FI
Finland
Prior art keywords
estradiol
precursor
group
blocking group
drug delivery
Prior art date
Application number
FI972579A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972579A0 (fi
FI972579A (fi
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of FI972579A0 publication Critical patent/FI972579A0/fi
Publication of FI972579A publication Critical patent/FI972579A/fi
Application granted granted Critical
Publication of FI119414B publication Critical patent/FI119414B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI972579A 1994-12-19 1997-06-17 Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17beta-estradioliprekursoreiden antamiseksi FI119414B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES940976 1994-12-19
IES950247 1995-04-05
IES950247 1995-04-05
PCT/IE1995/000063 WO1996019196A1 (en) 1994-12-19 1995-12-19 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
IE9500063 1995-12-19

Publications (3)

Publication Number Publication Date
FI972579A0 FI972579A0 (fi) 1997-06-17
FI972579A FI972579A (fi) 1997-06-17
FI119414B true FI119414B (fi) 2008-11-14

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972579A FI119414B (fi) 1994-12-19 1997-06-17 Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17beta-estradioliprekursoreiden antamiseksi

Country Status (19)

Country Link
US (1) US5855906A (tr)
EP (1) EP0799025B1 (tr)
JP (1) JPH10510825A (tr)
CN (1) CN1138526C (tr)
AR (1) AR002010A1 (tr)
AT (1) ATE178204T1 (tr)
AU (1) AU692659B2 (tr)
CA (1) CA2207622C (tr)
DE (1) DE69508791T2 (tr)
DK (1) DK0799025T3 (tr)
ES (1) ES2133841T3 (tr)
FI (1) FI119414B (tr)
GR (1) GR3030614T3 (tr)
IL (1) IL116433A (tr)
NO (1) NO316707B1 (tr)
NZ (1) NZ298490A (tr)
PE (1) PE62796A1 (tr)
TR (1) TR199501599A2 (tr)
WO (1) WO1996019196A1 (tr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
DK0981327T3 (da) * 1997-05-07 2003-03-10 Galen Chemicals Ltd Intravaginale lægemiddeltilførselsanordninger til indgivelse af testosteron og testosteronprecursorer
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EP1853221A2 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
DK1933810T3 (da) 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
KR101377900B1 (ko) 2005-10-13 2014-03-27 신세스 게엠바하 약물-함침 용기
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
RU2444364C2 (ru) * 2006-07-12 2012-03-10 Контроллд Терапьютикс (Скотлэнд) Лтд. Полимер для доставки лекарств с гидрохлоридной солью клиндамицина
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
ES2696999T3 (es) * 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Dispositivos de administración intravaginal de medicamentos para la administración de macromoléculas y medicamentos solubles en agua
EP2231254B9 (en) 2007-12-11 2015-04-08 Massachusetts Institute of Technology Implantable drug delivery device
BRPI0917135A2 (pt) 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
CN102596097B (zh) 2009-06-03 2015-05-20 弗赛特实验室有限责任公司 一种眼插入件
SG177362A1 (en) 2009-06-26 2012-02-28 Taris Biomedical Inc Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2012096985A1 (en) 2011-01-10 2012-07-19 Taris Biomedical, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
AU2012308317B2 (en) 2011-09-14 2017-01-05 Forsight Vision5, Inc. Ocular insert apparatus and methods
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
SI2911623T1 (sl) 2012-10-26 2019-12-31 Forsight Vision5, Inc. Oftalmični sistem za podaljšano sproščanje zdravila v oko
WO2014145638A1 (en) 2013-03-15 2014-09-18 Taris Biomedical, Inc Drug delivery devices with drug-permeable component and methods
BR112015032045B1 (pt) 2013-06-21 2020-06-09 Depuy Synthes Products Inc corpo flexível, método para formar um filme multicamadas para uso em combinação com um dispositivo médico implantável, sistema de armazenamento de filme e sistema para tratamento ortopédico
SG10202004675QA (en) 2013-08-19 2020-06-29 Taris Biomedical Llc Multi-unit drug delivery devices and methods
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA2944436C (en) * 2014-04-01 2023-08-22 Poly-Med, Inc. Contraceptive and related device
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
CN1138526C (zh) 2004-02-18
ES2133841T3 (es) 1999-09-16
DK0799025T3 (da) 1999-10-18
EP0799025A1 (en) 1997-10-08
NO316707B1 (no) 2004-04-13
GR3030614T3 (en) 1999-10-29
FI972579A0 (fi) 1997-06-17
US5855906A (en) 1999-01-05
NO972798L (no) 1997-08-19
DE69508791D1 (de) 1999-05-06
JPH10510825A (ja) 1998-10-20
EP0799025B1 (en) 1999-03-31
NO972798D0 (no) 1997-06-17
TR199501599A2 (tr) 1996-07-21
CN1170353A (zh) 1998-01-14
CA2207622A1 (en) 1996-06-27
ATE178204T1 (de) 1999-04-15
AU4399196A (en) 1996-07-10
PE62796A1 (es) 1996-12-28
CA2207622C (en) 2006-10-17
NZ298490A (en) 1999-11-29
FI972579A (fi) 1997-06-17
IL116433A (en) 2002-02-10
WO1996019196A1 (en) 1996-06-27
DE69508791T2 (de) 1999-12-02
AR002010A1 (es) 1998-01-07
IL116433A0 (en) 1996-03-31
AU692659B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
FI119414B (fi) Emättimensisäisesti käytettävät lääkkeen vapauttamislaitteet 17beta-estradioliprekursoreiden antamiseksi
US8865200B2 (en) Sustained release compositions containing progesterone receptor modulators
JP3806197B2 (ja) 腟内薬剤放出器具
EP0710491B1 (en) Subdermally implantable device
ES2247054T3 (es) Combinacion farmaceutica de drospirenona micronizada y un estrogeno para terapia hormonal de sustitucion.
NZ501236A (en) Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath
US5188835A (en) Intravaginal devices
KR920005824B1 (ko) 질 내 삽입용 기구
Victor et al. Vaginal progesterone for contraception
CA2309745A1 (en) Progestogen-antiprogestogen regimens
Kind et al. Sustained release hormonal preparations
IES68528B2 (en) Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors
EP0692965A1 (en) Method and composition for treatment of osteoporosis
Benagiano et al. Long Acting Polydimethylsiloxane Implants for Contraception

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119414

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: WARNER CHILCOTT (IRELAND) LIMITED

Free format text: WARNER CHILCOTT (IRELAND) LIMITED

MA Patent expired